1339 ALD2510: next generation Fc-enhanced, T REG -selective and IL-2-sparing anti-CD25 antibody with promising potential for the treatment of gynecological cancers

التفاصيل البيبلوغرافية
العنوان:	1339 ALD2510: next generation Fc-enhanced, T REG -selective and IL-2-sparing anti-CD25 antibody with promising potential for the treatment of gynecological cancers
المؤلفون:	Houacine, Jemila, Abes, Riad, Marie-Cardine, Anne, LeRoy, Aude, Giustiniani, Jerôme, Chrétien, Anne-Sophie, Fattori, Stéphane, Gorvel, Laurent, Bensussan, Armand, Olive, Daniel, Foussat, Arnaud
المصدر:	Regular and Young Investigator Award Abstracts ; page A1390-A1390
بيانات النشر:	BMJ Publishing Group Ltd
سنة النشر:	2022
نوع الوثيقة:	conference object
اللغة:	unknown
DOI:	10.1136/jitc-2022-sitc2022.1339
DOI:	10.1136/jitc-2022-SITC2022.1339
الاتاحة:	http://dx.doi.org/10.1136/jitc-2022-sitc2022.1339 https://syndication.highwire.org/content/doi/10.1136/jitc-2022-SITC2022.1339
رقم الانضمام:	edsbas.85F3B0DF
قاعدة البيانات:	BASE

الوصف
DOI:	10.1136/jitc-2022-sitc2022.1339